Jonathan H. Watanabe

MedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Associations of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use with Colorectal Cancer Risk in the Women's Health Initiative”.

Associations of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use with Colorectal Cancer Risk in the Women's Health Initiative

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-20-1401

N/A

0DataRank · unranked

9 citations

Katrina F. Flores, Joseph C. Larson, Alison M. Newton, Aladdin H. Shadyab, Jonathan H. Watanabe +4 more

Association of Pre-Pandemic Telehealth With Emergency Department and Telehealth Usage During the Pandemic

The Senior Care Pharmacist(2024)10.4140/tcp.n.2024.105

N/A

0DataRank · unranked

0 citations

Jonathan H. Watanabe, Michael W. Strand

Impact of Incretin Mimetics on Thyroid Cancer Among Patients with Type 2 Diabetes: A Retrospective Cohort Time-to-Event Analysis

Pharmacoepidemiology(2025)10.3390/pharma4020009

N/A

0DataRank · unranked

1 citations

Daniel Chow, Weining Shen, Jonathan H. Watanabe, Michael W. Strand